These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9184168)

  • 1. Inhibition of P-glycoprotein ATPase activity by beryllium fluoride.
    Sankaran B; Bhagat S; Senior AE
    Biochemistry; 1997 Jun; 36(22):6847-53. PubMed ID: 9184168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of P-glycoprotein ATPase activity by procedures involving trapping of nucleotide in catalytic sites.
    Sankaran B; Bhagat S; Senior AE
    Arch Biochem Biophys; 1997 May; 341(1):160-9. PubMed ID: 9143365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
    Urbatsch IL; Sankaran B; Weber J; Senior AE
    J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both P-glycoprotein nucleotide-binding sites are catalytically active.
    Urbatsch IL; Sankaran B; Bhagat S; Senior AE
    J Biol Chem; 1995 Nov; 270(45):26956-61. PubMed ID: 7592942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US
    Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.
    Sauna ZE; Nandigama K; Ambudkar SV
    J Biol Chem; 2004 Nov; 279(47):48855-64. PubMed ID: 15364914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites.
    Senior AE; Bhagat S
    Biochemistry; 1998 Jan; 37(3):831-6. PubMed ID: 9454572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic mechanism of P-glycoprotein.
    Senior AE
    Acta Physiol Scand Suppl; 1998 Aug; 643():213-8. PubMed ID: 9789563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic properties of actin. Structural changes induced by beryllium fluoride.
    Muhlrad A; Cheung P; Phan BC; Miller C; Reisler E
    J Biol Chem; 1994 Apr; 269(16):11852-8. PubMed ID: 8163484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
    Sauna ZE; Smith MM; Muller M; Ambudkar SV
    J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
    Urbatsch IL; Beaudet L; Carrier I; Gros P
    Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition state complexes of the Klebsiella pneumoniae nitrogenase proteins. Spectroscopic properties of aluminium fluoride-stabilized and beryllium fluoride-stabilized MgADP complexes reveal conformational differences of the Fe protein.
    Miller RW; Eady RR; Fairhurst SA; Gormal CA; Smith BE
    Eur J Biochem; 2001 Feb; 268(3):809-18. PubMed ID: 11168422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of myosin ATPase by beryllium fluoride.
    Phan B; Reisler E
    Biochemistry; 1992 May; 31(20):4787-93. PubMed ID: 1534258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6).
    Cai J; Daoud R; Alqawi O; Georges E; Pelletier J; Gros P
    Biochemistry; 2002 Jun; 41(25):8058-67. PubMed ID: 12069597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R; Sharom FJ
    Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates.
    Kerr KM; Sauna ZE; Ambudkar SV
    J Biol Chem; 2001 Mar; 276(12):8657-64. PubMed ID: 11121420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labelling of P-glycoprotein catalytic sites.
    Sankaran B; Bhagat S; Senior AE
    FEBS Lett; 1997 Nov; 417(1):119-22. PubMed ID: 9395088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.
    Russell PL; Sharom FJ
    Biochem J; 2006 Oct; 399(2):315-23. PubMed ID: 16803457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.